SUN-627 for Multiple Sclerosis
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this Phase 2 clinical trial is to investigate the safety and tolerability of SUN-627 in men and women aged 18-70 years old with a diagnosis of non-active SPMS/PPMS.
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-70 who have been diagnosed with non-active secondary progressive or primary progressive multiple sclerosis (SPMS/PPMS).Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- SUN-627
Trial Overview
The study is testing a new drug called SUN-627 compared to a placebo. Participants are randomly assigned to receive either the drug or an inactive substance, and researchers will monitor safety and how well people tolerate it.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
SUN-627, taken orally QD
SUN-627, taken orally QD
SUN-627 Placebo, taken orally QD
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sundance Biosciences, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.